Erythropoietin ameliorates hyperglycemia in type 1-like diabetic rats

BACKGROUND: Erythropoietin (EPO) is widely used in diabetic patients receiving hemodialysis. The role of EPO in glucose homeostasis remains unclear. Therefore, we investigated the effect of EPO on hyperglycemia in rats with type 1-like diabetes. METHODS: Rats with streptozotocin-induced type 1-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Ho-Shan, Chang, Chin-Hong, Niu, Chiang-Shan, Cheng, Juei-Tang, Lee, Kung-Shing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902144/
https://www.ncbi.nlm.nih.gov/pubmed/27350742
http://dx.doi.org/10.2147/DDDT.S105867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902144/
https://www.ncbi.nlm.nih.gov/pubmed/27350742
http://dx.doi.org/10.2147/DDDT.S105867

Ejemplares similares